Spots Global Cancer Trial Database for Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
Official Title: Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
Study ID: NCT00785694
Conditions
Interventions
Study Description
Brief Summary: This is a randomised, comparative, multicentre study to determine if the early recurrence rate of intermediate-risk bladder cancer is similar in subjects treated with multiple instillations of mitomycin C after resection conducted under white light cystoscopy (group A) and subjects treated with 1 instillation of mitomycin C after resection conducted under white light and blue light cystoscopy (group B).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GE Healthcare Medical Diagnostics, Velizy Cedex, Morane Saulnier, France
Contact Details
Name: Jean-Paul Antonini
Affiliation: GE Healthcare
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
